DISC-0974
A Phase 1b/2a Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1/2
- Enrollment
- 56 patients (estimated)
- Sponsors
- Disc Medicine, Inc
- Tags
- Monoclonal Antibody, Hemojuvelin (HJV), Monotherapy, Randomization
- Trial Type
- Supportive
- Last Update
- 5 days ago
- SparkCures ID
- 1957
- NCT Identifier
- NCT05320198
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.